Wilms' Tumor Gene (WT1) Expression Correlates with Vascular Epithelial Growth Factor (VEGF) in Newly Acute Leukemia Patients Undergoing Chemotherapy |
Iranparast, Sara
(Immunology Department, Ahvaz Jundishapur University of Medical Sciences)
Assarehzadegan, Mohammad-Ali (Immunology Department, Ahvaz Jundishapur University of Medical Sciences) Heike, Yuji (Department of Hematopoietic Stem cell Transplantation, National Cancer Hospital) Hossienzadeh, Mehran (Shafa Medical Center, Ahvaz Jundishapur University of Medical Sciences) Khodadadi, Ali (Immunology Department, Ahvaz Jundishapur University of Medical Sciences) |
1 | Achen MG, Williams RA, Minekus MP, et al (2001). Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J Pathol, 193, 147-54. DOI |
2 | Caldon CE, Lee CS, Sutherland RL, Musgrove EA (2008). Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene, 27, 126-38 DOI |
3 | Cash J, Korchnak A, Gorman J, Tandon Y, Fraizer G (2007). VEGF transcription and mRNA stability are altered by WT1 not DDS (R384W) expression in LNCaP cells. Oncol Rep, 17, 1413-9. |
4 | Daniela Cilloni, Francesca Messa, Arruga F (2008). Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1transcript levels in peripheral blood samples collected after chemotherapy. Haematologica, 93, 921-4. DOI |
5 | Dohi S, Ohno S, Ohno Y, et al (2010). WT1 expression correlates with angiogenesis in endometrial cancer tissue. Anticancer Res, 30, 3187-92. |
6 | Gao L (2000). Selective elimination of leukemic CD34 (+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood, 95, 2198-203. |
7 | Gao L (2003). Human cytotoxic T lymphocytes specific for Wilms' tumor antigen- 1 inhibit engraftment of leukemiainitiating stem cells in non-obese diabetic-severe combined immunodeficient recipients. Transplantation, 75, 1429-36. DOI |
8 | Gessler M, Poustka A, Cavenee W, et al (1990). Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-8. DOI ScienceOn |
9 | Graham K, Li W, Williams B, Fraizer G (2006). VEGF is differentially expressed in T1- and DDS-LNCaP cells. Gene Expression, 13, 1-14. DOI |
10 | Gregory McCarty OA, Loeb DM (2011. december). WT1 Protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. journal of biological chemistry, 286. |
11 | Haber DA, Buckler AJ, T G (1990). An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61, 1257-69. DOI |
12 | Hanson J, Gorman J, Reese J (2007). Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci, 12, 2279-90. DOI |
13 | Hashiba T, Izumoto S, Kagawa N, et al (2007). Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir, 47, 165-70. DOI |
14 | Hayes DF (2005). Prognostic and predictive factors revisited. Breast, 14, 493-9. DOI ScienceOn |
15 | Hylander B, Repasky E, Shrikant P, et al (2006). Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol, 101, 12-7. DOI |
16 | Inoue K, Ogawa H, Sonoda Y, et al (1997). Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89, 1405-12 |
17 | Keilholz U1, Menssen HD, Gaiger A, et al (2005). Wilms' tumor gene 1 (WT1) in human neoplasia. Leukemia, 19, 1318-23. DOI |
18 | Kreidberg JA, Sariola H, Loring JM, et al (1993). WT-1 is required for early kidney development. Cell, 74, 679-91. DOI |
19 | Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H (1994). Vascular endothelila growth factor / vascular permeability factor is detectable in the sera of tumor bearing mice and cancer patients. Biochim Acta Biophys, 1221, 211-4. DOI ScienceOn |
20 | Korosh E, Mohammad MG, Rashid R (2012). Report of national cancer registration 2010. |
21 | Kusumoto S MI, Bessho M, Matsumoto H M S (1999). The importance of WT1 gene expression in the detection of minimal residual disease. A comparison of WT1 AML/MTG8 transcripts. Rinsho Ketsueki, 40, 511-4. |
22 | Lee J, Gray A, Yuan J (1996). Vascular endothelial growth factorrelated protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A, 93, 1988-92. DOI ScienceOn |
23 | Maglione D, Guerriero V, Vigeltto G, Persico M, Delli-Bovi P (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA, 88, 9267-71. DOI ScienceOn |
24 | Martin SK, To LB, Horvath N, Zannettino ACW (2004). Angiogenesis in multiple myeloma: implications in myeloma therapy. Cancer Rev A Pac, 02, 119-129. DOI |
25 | McCarty G, Awad O, DM L (2011). WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. J Biol Chem, 286, 51. |
26 | Oji Y, Miyoshi S, Maeda H, et al (2002). Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer, 100, 297-303 DOI |
27 | Meyer M, Clauss M, Lepple-Wienhues A, et al (1999). A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J, 18, 363-74. DOI ScienceOn |
28 | Miyoshi Y, Ando A, Egawa C, et al (2002). High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. 8, 1167-71. |
29 | Moazam MM, Eisermann K, Fraizer G (2010). Identifying a role for WT1 in pediatric leukemia. J Clin Oncol, 28. |
30 | Oji Y, Ogawa H, Tamaki H, et al (1999). Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res, 90, 194-204. DOI |
31 | Oka Y, Tsuboi A, Kawakami M, et al (2006). Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers. Curr Med Chem, 13, 2345-52. DOI |
32 | Olofsson B, Pajusola K, Kaipainen A, et al (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA, 93, 2576-81 DOI ScienceOn |
33 | Ozalp S, Yalcin OT, Acikalin M, et al (2003). Microvessel density (MVD) as a prognosticator in endometrial carcinoma. Eur J Gynaecol Oncol, 24, 305-8. |
34 | Phipps, Wilma J, Donovan F (2007). Medical-surgical nursing,7 Ed, Lippincott W, Wilkins. |
35 | Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S (2000). Immunohisto-chemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol, 19, 158-63. DOI |
36 | Rini B (2007). Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res, 13, 741-6 DOI ScienceOn |
37 | Scharnhorst V, van der Eb AJ, Jochemsen AG (2001). WT1 proteins: functions in growth anddifferentiation. Gene, 273, 141-61 DOI |
38 | Sera T, Hiasa Y, Mashiba T, et al (2008). Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis. Eur J Cancer, 44, 600-8. DOI |
39 | Sugiyama H (2001). Wilms' tumor gene WT1: its oncogenic function and clinical application. Int J Hematol, 73, 177-87. DOI |
40 | Wagner N1, Panelos J, Massi D, Wagner KD (2008). The Wilms' tumor suppressor WT1 is associated with melanoma proliferation. Pflugers Arch, 455, 839-47. DOI |
41 | Xue SA (2005). Elimination of human leukemia cells in NOD/SCID mice by WT1- TCR gene-transduced human T cells. Blood, 106, 3062-7. DOI |
42 | Yamamoto S, Tsuda H KT, Maekawa K, et al (2007). Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch, 451, 27-35. DOI |
43 | Zamora-Avila DE1, Franco-Molina MA, Trejo-Avila LM, et al (2007). RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line. Melanoma Res, 17, 341-8. DOI |
44 | Zapata-Benavides P1, Tuna M, Lopez-Berestein G, Tari AM (2002). Down-regulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun, 295, 784-90 DOI |
45 | Zand A M, Imani S, Saadati M, et al (2012). Statistical approach to discovery of factors impacting on emergence of blood cancers in Iran. Asian Pac J Cancer Prev, 13, 5965-7 과학기술학회마을 DOI |